1 |
Ellington, A. D. and J. W. Szostak. 1990. In vitro selection of RNA molecules that bind specific ligands. Nature 346: 818-822
DOI
ScienceOn
|
2 |
Fried, M. W., M. L. Shiffman, K. R. Reddy, C. Smith, G. Marinos, F. L. Jr. Goncales, D. Haussinger, M. Diago, G. Carosi, D. Dhumeaux, A. Craxi, A. Lin, J. Hoffman, and J. Yu. 2002. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N. Engl. J. Med. 347: 975-982
DOI
ScienceOn
|
3 |
Fukuda, K., D. Vishnuvardhan, S. Sekiya, J. Hwang, N. Kakiuchi, K. Taira, K. Shimotohno, P. K. Kumar, and S. Nishikawa. 2000. Isolation and characterization of RNA aptamers specific for the hepatitis C virus non structural protein 3 protease. Eur. J. Biochem. 267: 3685-3694
DOI
ScienceOn
|
4 |
Hwang, B., J. S. Cho, H. J. Yeo, J.-H. Kim, K. M. Chung, K. Han, S. K. Jang, and S.-W. Lee. 2004. Isolation of specific and high-affinity RNA aptamers against NS3 helicase domain of hepatitis C virus. RNA 10: 1277-1290
DOI
ScienceOn
|
5 |
Kwong, A. D., J. L. Kim, and C. Lin. 2000. Structure and function of hepatitis C virus NS3 helicase. Curr. Top. Microbiol. Immunol. 242: 171-196
|
6 |
Penin, F., J. Dubuisson, F. Rey, D. Moradpour, and J.-M. Pawlotsky. 2004. Structural biology of hepatitis C virus. Hepatology 39: 5-19
DOI
ScienceOn
|
7 |
Urvil, P. T., N. Kakiuchi, D.-M. Zhou, K. Shimotohno, P. K. R. Kumar, and S. Nishikawa. 1997. Selection of RNA aptamers that bind specifically to the NS3 protease of hepatitis C virus. Eur. J. Biochem. 248: 130-138
DOI
ScienceOn
|
8 |
Jaeger, S., G. Eriani, and F. Martin. 2004. Results and prospects of the yeast three-hybrid system. FEBS Lett. 556: 7-12
DOI
PUBMED
ScienceOn
|
9 |
Hugle, T. and A. Cerny. 2003. Current therapy and new molecular approaches to antiviral treatment and prevention of hepatitis C. Rev. Med. Virol. 13: 361-371
DOI
ScienceOn
|
10 |
Vo, N. V., J. W. Oh, and M. M. Lai. 2003. Identification of RNA Iigands that bind hepatitis C virus polymerase selectively and inhibit its RNA synthesis from the natural viral RNA templates. Virology 307: 301-316
DOI
ScienceOn
|
11 |
Cassiday, L. and L. J. Maher, III. 2001. In vivo recognition of an RNA aptamer by its transcription factor target. Biochemistry 40: 2433-2438
DOI
ScienceOn
|
12 |
Lauer, G. M. and B. D. Walker. 2001. Hepatitis C virus infection. N. Engl. J. Med. 345: 41-52
DOI
ScienceOn
|
13 |
Biroccio, A., J. Hamm, I. Incitti, R. De Francesco, and L. Tomei. 2002. Selection of RNA aptamers that are specific and high-affinity ligands of the hepatitis C virus RNA-dependent RNA polymerase. J. Virol. 76: 3688-3696
DOI
ScienceOn
|
14 |
Baek, C.-H. and K.-S. Kim. 2003. lacz- and aph-based reporter vectors for in vivo expression technology. J. Microbiol. Biotechnol. 13: 872-880
|
15 |
SenGupta, D. J., B. Zhang, B. Kraemer, P. Pochart, S. Fields, and M. Wickens. 1996. A three-hybrid system to detect RNA-protein interactions in vivo. Proc. Natl. Acad. Sci. USA 93: 8496-8501
|
16 |
Sullenger, B. A. and E. Gilboa. 2002. Emerging clinical applications of RNA. Nature 418: 252-258
DOI
ScienceOn
|
17 |
Klausner, R. D., T. A. Rouault, and J. B. Harford. 1993. Regulating the fate of mRNA: The control of cellular iron metabolism. Cell 72: 19-28
DOI
ScienceOn
|
18 |
Tuerk, C. and L. Gold. 1990. Systematic evolution ofligands by exponential enrichment: RNA Iigands to bacteriophage T4 DNA polymerase. Science 249: 505-510
DOI
PUBMED
|
19 |
Zuker, M. 2003. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res. 31: 3406-3415
DOI
PUBMED
ScienceOn
|
20 |
Kumar, P. K., K. Machida, P. T. Urvil, N. Kakiuchi, D. Vishnuvardhan, K. Shimotohno, K. Taira, and S. Nishikawa, 1997. Isolation of RNA aptamers specific to the NS3 protein of hepatitis C virus from a pool of completely random RNA. Virology 237: 270-282
DOI
PUBMED
ScienceOn
|